Management Team

Víctor Cervera-Carrascón

M.Pharm, Head of Immunology

Head of Immunology, Víctor Cervera-Carrascón, has expertise in immunotherapy, particularly on the use of oncolytic viruses to enable immune checkpoint blockade and other T-cell related approaches. Victor is completing a PhD from the Marie Skłodowska-Curie consortium (Netherlands and Finland) in oncolytic viruses. Victor is responsible for, in particular, work with oncolytic viruses and checkpoint inhibitors and is translating preclinical success into clinical trials, as well as supporting business development.

Akseli Hemminki

MD, PhD, eMBA, Founder & CEO and Chairman of the Board

Aino Kalervo

MSc, MS, Chief Business Officer

Kari Varkila

MD, PhD, MBA, Chief Medical Officer

Tuija Keinonen

PhD, Chief Regulatory Officer

Elina Haavisto

MSc, Head of CMC Regulatory Affairs

Claudia Kistler

PhD, Head of Clinical Operations

Riikka Havunen

PhD, Head of R&D

Riikka Kalliokoski

Bachelor of Social and Health Care, Lab manager

João Manuel Santos

MSc, Head of Cell Therapy

no image

Suvi Sorsa

PhD, Head of Clinical Research

Remi Gloeckler

PhD, CMC Advisor